Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ocean Wilsons pleased with performance, Brazil sale on track

(Sharecast News) - Ocean Wilsons Holdings said in an update on Friday that it remained on track to complete the sale of its Brazilian maritime subsidiary Wilson Sons in the second quarter, subject to final regulatory approvals. The FTSE 250 company said the transaction, agreed with MSC Mediterranean Shipping Company for BRL 4.35bn (£0.58bn), was expected to generate net cash proceeds of at least $593m, based on exchange rates at the time of the October announcement.

It reiterated its intention to return a portion of the proceeds to shareholders via a tender offer for up to 20% of its issued share capital, with further details to follow post-completion.

As at 31 March, Ocean Wilsons reported an implied net asset value per share of $27.20, supported by a $321.2m investment portfolio and $47.4m in holding company cash.

The investment portfolio fell 1.3% in the quarter, which the company described as a solid outcome amid heightened equity market volatility driven by global tariff concerns.

Private equity holdings and diversification contributed positively despite broader market weakness.

Wilson Sons reportedly delivered a strong first quarter, with net revenue rising 1.5% year-on-year to $131.3m and profit up 56.1% to $33.1m, buoyed by a robust performance in logistics and towage.

Ocean Wilsons said it would pay a dividend of $1.22 per share on 28 May, as approved at its recent annual general meeting.

At 1200 BST, shares in Ocean Wilsons Holdings were up 1.89% at 1,345p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.